NUTLEY, NJ – more than 400 DuPont Tyvek Bacteria suits; more than 500 Kimtec bacterial masks; and in excess of 1,000 personal hygiene kits each containing four masks, latex gloves, a disposable thermometer, hand sanitizer and sterile wipes.were delivered to Hackensack Meridian Health’s Hackensack University Medical Center…
Hackensack Meridian Health announced that a rapid test for COVID-19 created by its labs at the Center for Discovery and Innovation (CDI) has been licensed to T2 Biosystems, a Massachusetts-based leader of in-vitro diagnostics.
Hackensack Meridian Health has gotten U.S. Food & Drug Administration approval to begin using the COVID-19 test it developed in its Center for Discovery and Innovation.
U.S. Senator Bob Menendez and a senior member of the Senate Finance Committee today toured the lab at Hackensack Meridian Health’s Center…
Researchers at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) are currently developing rapid response diagnostic tests for the coronavirus.
Ordinances and resolutions related to Phase IIA of the On3 site, formerly the Hoffmann-La Roche campus, were approved during the Nutley Board of Commissioners Tuesday, Feb. 4 public meeting.
Prism Capital Partners announced it has relocated its headquarters to ON3, its 116-acre campus on the border of Clifton and Nutley.
Reflecting on a significant period of growth, Prism Capital Partners said Friday that it moved its headquarters from Bloomfield to ON3, the commercial real estate owner/operator’s 116-acre redevelopment spanning the Township of Nutley and City of Clifton.
Genomic medicine’s groundbreaking treatments, and its future promise, will be the focus of a full-day symposium at the Hackensack Meridian Health Center for Discovery and Innovation (CDI) on Wednesday, February 19.
Topology representatives Philip Abramson, founder and CEO and Christopher Colley, a development analyst gave an update on the data they collected and conclusions from the survey responses on the On3 site….